| 104144-1 | Mental health Advance directives | DOC.ONTOLOGY |
| 104145-8 | Left ventricular Ejection fraction - upper limit (us.2d.a2c+estimated) | CARD.US |
| 104146-6 | Left ventricular Ejection fraction - upper limit (us.2d.a3c+estimated) | CARD.US |
| 104147-4 | Left ventricular Ejection fraction - upper limit (us.3d.a3c+estimated) | CARD.US |
| 104148-2 | Left ventricular Ejection fraction - upper limit (us.3d.a4c+estimated) | CARD.US |
| 104149-0 | Left ventricular Ejection fraction (us.2d.a2c+calculated by biplane method) | CARD.US |
| 10415-8 | Transfuse blood exchange transfusion | BLDBK |
| 104150-8 | Left ventricular Ejection fraction (us.2d.a3c+calculated by biplane method) | CARD.US |
| 104151-6 | Left ventricular Ejection fraction (us.2d.a4c+calculed by biplane method) | CARD.US |
| 104152-4 | Left ventricular Ejection fraction (us.3d.a2c+calculated by biplane method) | CARD.US |
| 104153-2 | Left ventricular Ejection fraction (us.3d.a3c+calculated by biplane method) | CARD.US |
| 104154-0 | Left ventricular Ejection fraction (us.3d.a4c+calculated by biplane method) | CARD.US |
| 104155-7 | Left ventricular Ejection fraction - upper limit (us.3d.a2c+estimated) | CARD.US |
| 104156-5 | Condition frequency - Reported (qualitative) | H&P.HX |
| 104157-3 | Left ventricular Ejection fraction - upper limit (us.2d.a4c+estimated) | CARD.US |
| 104158-1 | Associated precondition - Reported (qualitative) | H&P.HX |
| 104159-9 | Left ventricular Maximum longitudinal strain (us.2d+calculated by average triplane method) | HEMODYN.MOLEC |
| 10416-6 | Transfuse blood product other | BLDBK |
| 104160-7 | Left ventricular End-systolic volume (by US.2D.A2C+Calculated (biplane area-length method)/body surface area) | HEMODYN.MOLEC |
| 104161-5 | Left ventricular End-systolic volume/Body surface area (us.2d.a4c+calculated by biplane area-length method) | HEMODYN.MOLEC |
| 104162-3 | Left ventricular End-systolic volume/Body surface area (us.3d.a2c+calculated by biplane area-length method) | HEMODYN.MOLEC |
| 104163-1 | Left ventricular End-systolic volume/Body surface area (us.3d.a4c+calculated by biplane area-length method) | HEMODYN.MOLEC |
| 104164-9 | Pulmonary artery Pressure (us.doppler) | CARD.US |
| 104165-6 | Aortic valve Orifice area/Body surface area (us 2d) | CARD.US |
| 104166-4 | Apolipoprotein E phenotype (lc/ms/ms) | CHEM |
| 104167-2 | TRCA+TCRD gene rearrangements (Bone Marrow, fish) | MOLPATH |
| 104168-0 | TCL-1A gene rearrangements (Bone Marrow, fish) | MOLPATH |
| 104169-8 | D13S319 deletion (Bone Marrow, fish) | MOLPATH |
| 10417-4 | Transfuse cryoprecipitate | BLDBK |
| 104170-6 | Human papilloma virus 31+33+52+58 DNA in Cervix (qualitative, naa with probe detection) | MICRO |
| 104171-4 | DPYD gene.c.2846A>T or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104172-2 | DPYD gene.c.1236G>A or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104173-0 | DPYD gene.c.1905+1G>A or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104174-8 | DPYD gene.c.1679T>G or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104175-5 | Clostridium tetani toxin TeNT gene in Specimen (qualitative, naa with non-probe detection) | MICRO |
| 104176-3 | Clostridium tetani toxin TeNT gene in Specimen (qualitative, naa with probe detection) | MICRO |
| 104177-1 | Clostridium tetani toxin in Specimen (qualitative, mouse bioassay neutralization) | MICRO |
| 104178-9 | Clostridium tetani toxin in Specimen (qualitative, immunoassay) | MICRO |
| 104179-7 | Clostridium tetani toxin in Specimen (qualitative, endopeptidase assay) | MICRO |
| 10418-2 | Transfuse factor IX | BLDBK |
| 104180-5 | Clostridium tetani toxin (qualitative, endopeptidase assay) | MICRO |
| 104181-3 | Clostridium tetani toxin (qualitative, mouse bioassay) | MICRO |
| 104182-1 | Clostridium tetani toxin (qualitative, immunoassay) | MICRO |
| 104183-9 | Adenovirus DNA in Conjunctival specimen (qualitative, naa with probe detection) | MICRO |
| 104184-7 | Maternal condition that affected the fetus Mother | OBGYN |
| 104185-4 | Fetal Secondary cause of death | OBGYN |
| 104186-2 | Fetal Reason for death | OBGYN |
| 104187-0 | Disease onset to death interval duration | OBGYN |
| 104188-8 | Mucopolysaccharidosis type II newborn screening panel | PANEL.CHEM |
| 104189-6 | Mucopolysaccharidosis type II newborn screen interpretation newborn screen interpretation | CHEM |